Ubs Asset Management Americas Inc Repligen Corp Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Repligen Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 235,343 shares of RGEN stock, worth $36.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

235,343

Previous 208,610 12.81%

Holding current value

$36.8 Million

Previous $31 Million 9.12%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $3.3 Million - $4.3 Million	26,733 Added 12.81%	235,343 $33.9 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $17.4 Million - $24.3 Million	-145,254 Reduced 41.05%	208,610 $31 Million
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $10.8 Million - $16.4 Million	89,801 Added 34.01%	353,864 $44.6 Million
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $171,463 - $209,253	1,004 Added 0.38%	264,063 $48.6 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $1.78 Million - $2.89 Million	15,614 Added 6.31%	263,059 $47.3 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $7.67 Million - $9.75 Million	55,258 Added 28.75%	247,445 $39.3 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $526,026 - $675,521	3,410 Added 1.81%	192,187 $32.4 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $6.29 Million - $8.54 Million	38,736 Added 25.82%	188,777 $32 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.3 Million - $3.67 Million	-14,315 Reduced 8.71%	150,041 $28.1 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $316,952 - $423,609	2,253 Added 1.39%	164,356 $26.7 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $202,454 - $323,997	-1,256 Reduced 0.77%	162,103 $30.5 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $77,248 - $94,994	312 Added 0.19%	163,359 $43.3 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.21 Million - $2.01 Million	-6,199 Reduced 3.66%	163,047 $47.1 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $904,820 - $1.21 Million	-5,455 Reduced 3.12%	169,246 $33.8 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $385,631 - $483,743	-2,138 Reduced 1.21%	174,701 $34 Million
Q4 2020 Mar 01, 2021	SELL	$148.08 - $206.57 $781,714 - $1.09 Million	-5,279 Reduced 2.9%	176,839 $33.9 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $2.89 Million - $3.73 Million	23,580 Added 14.87%	182,118 $26.9 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $1.23 Million - $1.83 Million	13,036 Added 8.96%	158,538 $19.6 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $7.88 Million - $10.1 Million	92,761 Added 175.88%	145,502 $14 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $369,790 - $466,144	5,008 Added 10.49%	52,741 $4.88 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $587,139 - $731,606	7,660 Added 19.12%	47,733 $3.66 Million
Q2 2019 Aug 15, 2019	BUY	$54.2 - $85.95 $411,052 - $651,844	7,584 Added 23.34%	40,073 $0
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $187,069 - $237,572	3,783 Added 13.18%	32,489 $0
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $89,329 - $127,496	1,851 Added 6.89%	28,706 $1.51 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $125,330 - $157,921	2,678 Added 11.08%	26,855 $0
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $202,004 - $269,492	5,729 Added 31.05%	24,177 $0
Q4 2017 Feb 09, 2018	BUY	$32.53 - $38.92 $26,642 - $31,875	819 Added 4.65%	18,448 $0
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $651,920 - $811,991	17,629	17,629 $0

Others Institutions Holding RGEN

# of Institutions

482

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.69B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Repligen Corp Transaction History